Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
NCT05634811
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
3547
Enrollment
INDUSTRY
Sponsor class
Conditions
Lyme Disease
Interventions
BIOLOGICAL:
VLA15
OTHER:
Normal Saline
Sponsor
Pfizer